PMGC Holdings Inc. Files S-1/A Amendment for IPO

Ticker: ELAB · Form: S-1/A · Filed: Apr 7, 2025 · CIK: 1840563

Sentiment: neutral

Topics: ipo, amendment, pharmaceutical

TL;DR

PMGC Holdings Inc. (fka Elevai Labs) filed S-1/A for IPO. Get ready.

AI Summary

PMGC Holdings Inc. filed an S-1/A amendment on April 7, 2025, for its initial public offering. The company, formerly known as Elevai Labs Inc. and Reactive Medical Labs Inc., is incorporated in Nevada and headquartered in Newport Beach, California. The filing relates to Registration No. 333-284851 under the Securities Act of 1933.

Why It Matters

This S-1/A filing indicates PMGC Holdings Inc. is moving forward with its public offering, providing investors with updated information on its business and financial status.

Risk Assessment

Risk Level: medium — As an S-1/A filing for an IPO, the company is still in the process of going public, which inherently carries higher risks than established public companies.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this S-1/A filing?

This is an amendment to a registration statement on Form S-1, indicating PMGC Holdings Inc. is providing updated information as part of its initial public offering process.

When was this amendment filed?

The amendment was filed with the U.S. Securities and Exchange Commission on April 7, 2025.

What were the previous names of PMGC Holdings Inc.?

The company was formerly known as Elevai Labs Inc. (name change effective 20211207) and Reactive Medical Labs Inc. (name change effective 20210114).

Where is PMGC Holdings Inc. located?

The company's principal executive offices are located at 120 Newport Center Drive, Ste. 249, Newport Beach, CA 92660.

Who is the CEO and CFO of PMGC Holdings Inc.?

Graydon Bensler serves as the Chief Executive Officer and Chief Financial Officer of PMGC Holdings Inc.

Filing Details

This Form S-1/A (Form S-1/A) was filed with the SEC on April 7, 2025 by Graydon Bensler regarding PMGC Holdings Inc. (ELAB).

View full filing on EDGAR

View Full Filing

View this S-1/A filing on SEC EDGAR

View on Read The Filing